NEW YORK (IFR) - A bank proposal to pool corporate bonds of a single borrower into an ETF-style “trust” to help solve the credit markets’ chronic illiquidity problem is being circulated among issuers and investors, and finding some support.
NEW YORK, May 11 (IFR) - Apple, Shell and AbbVie blitzed the
US bond market last week with a combined US$34bn of jumbo bond
deals in just two days, bringing the week's tally to US$52bn,
the fourth-largest of all time.
NEW YORK, April 17 (IFR) - Hedge fund pressure to break up
Qualcomm is not likely to be an obstacle when the world's
largest phone chip-maker comes to market as expected with a
jumbo bond to finance a share buyback.
NEW YORK, April 13 (IFR) - Mizuho took a giant leap towards
becoming a top 10 underwriter of US corporate bonds this month
by hiring 130 debt capital markets and corporate finance bankers
NEW YORK, April 10 (IFR) - Drugmaker Mylan is at risk of
dropping back into junk territory if it doesn't strike a perfect
balance between bond and equity to finance its proposed US$30bn
acquisition of healthcare supplier Perrigo, analysts warned.
NEW YORK Mizuho Bank [MZFGEU.UL] is expected to hire roughly 200 Royal Bank of Scotland [RBSRB.UL] employees as early as next week following its agreement to buy RBS's U.S. and Canadian $36.5 billion (£25 billion) loan portfolio, banking sources told Thomson Reuters LPC and IFR.
NEW YORK Mizuho Bank [MZFGEU.UL] is expected to hire roughly 200 Royal Bank of Scotland [RBSRB.UL] employees as early as next week following its agreement to buy RBS's U.S. and Canadian $36.5 billion loan portfolio, banking sources told Thomson Reuters LPC and IFR.
NEW YORK, Feb 13 (IFR) - Yield hungry European pension funds
and other non-US investors are diving into US corporate bonds at
a pace that bankers and asset managers said they haven't seen
since the financial crisis.
NEW YORK (IFR) - Microsoft took a leaf out of Apple's playbook on Monday and issued a US$10.75bn bond issue - the biggest so far this year - in part to return money to its shareholders.
NEW YORK, Feb 5 (IFR) - Merck & Co's US$8bn jumbo bond is
just the tip of the iceberg of debt supply from the healthcare
sector in the months ahead with brand names like Novartis and
Pfizer set to compete for investor cash.